Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROCRIT for Fatigue in Anemia of Chronic Disease Due to Rheumatoid Arthritis
NCT00236678Phase 2Terminated
- Sponsor
- Johnson & Johnson
- Start
- Jul 2004
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
Phase 2, randomised, double-blind trial in anemia of chronic disease (ACD) comparing PROCRIT with Placebo (2 arms). Primary endpoint: Changes in fatigue. Started Jul 2004; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia of chronic disease (ACD)
Beyond the preview
Go deeper on NCT00236678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236678.